专利检索 ap:("GlaxoSmithKline Intellectual Property (No.2) Limited") AND inv:"David Jonathan HIRST" 第 1 页

1.

发明申请
2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS 审中-公开

公开(公告)号：US20170189401A1

公开(公告)日：2017-07-06

申请号：US15466925

申请日：2017-03-23

申请人： GlaxoSmithKline Intellectual Property (No.2) Limited

发明人： Dominique AMANS , Stephen John ATKINSON , Lee Andrew HARRISON , David Jonathan HIRST , Robert Peter LAW , Matthew LINDON , Alexander PRESTON , Jonathan Thomas SEAL , Christopher Roland WELLAWAY

IPC分类号： A61K31/506

CPC分类号： A61K31/506 , A61K31/4375 , A61K31/4706 , A61K31/4709 , A61K31/496 , A61K31/497 , A61K31/5377 , A61K31/5386 , C07D215/227 , C07D215/44 , C07D215/46 , C07D215/48 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D471/08 , C07D487/08 , C07D498/04 , C07D498/08

摘要： The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

2.

发明申请
TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS 审中-公开

公开(公告)号：US20170298047A1

公开(公告)日：2017-10-19

申请号：US15509894

申请日：2015-09-09

申请人： GlaxoSmithKline Intellectual Property (No.2) Limited

发明人： Stephen John ATKINSON , David Jonathan HIRST , Philip G. HUMPHREYS , Matthew J. LINDON , Alexander G. PRESTON , Jonathan Thomas SEAL , Christopher Roland WELLAWAY

IPC分类号： C07D405/14 , C07D401/12

CPC分类号： C07D405/14 , C07D401/12

摘要： The present invention relates to specific novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy as bromodomain inhibitors.

3.

发明申请
2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS 审中-公开

公开(公告)号：US20180303831A1

公开(公告)日：2018-10-25

申请号：US16016955

申请日：2018-06-25

申请人： GlaxoSmithKline Intellectual Property (No.2) Limited

发明人： Dominique AMANS , Stephen John ATKINSON , Lee Andrew HARRISON , David Jonathan HIRST , Robert Peter LAW , Matthew LINDON , Alexander PRESTON , Jonathan Thomas SEAL , Christopher Roland WELLAWAY

IPC分类号： A61K31/506 , A61K31/497 , C07D401/14 , A61K31/4709 , A61K31/496 , C07D498/08 , A61K31/5377 , A61K31/5386 , A61K31/4375 , C07D498/04 , C07D487/08 , C07D471/08 , C07D471/04 , C07D417/14 , C07D417/12 , C07D413/12 , C07D413/04 , C07D409/14 , C07D409/12 , C07D405/04 , C07D401/12 , C07D401/04 , C07D215/48 , C07D215/46 , C07D215/44 , C07D215/227 , C07D413/14 , C07D405/14 , A61K31/4706

摘要： The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.